Oak Ridge researchers are converting nuclear waste into components for targeted alpha therapy, a cancer treatment that ...

Curadh MTR Inc. ("Curadh") and Alpha Fusion, Inc. ("Alpha Fusion") will present on the clinical development of radiopharmaceutical products at the upcoming 4th Targeted Radiopharmaceuticals Summit US ...

Thor Medical, which is working in a partnership with South Africa’s Steenkampskraal monazite mine (SMM), has made progress in ...

Neutrophils, once considered simple foot soldiers of innate immunity, are now recognized as complex players in cancer. This ...

Anixa Biosciences' breast cancer vaccine elicited targeted immune responses in 70% of patients. Click here to read an ...

Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR), a leading U.S. producer of uranium, rare earth elements, and critical minerals, will hold a conference call on Thursday, August 7, 2025, at 9:00 AM ...

Inhibrx Biosciences rises on early clinical success; Ozekibart shows promise in colorectal cancer. Read here for an analysis ...

Perspective Therapeutics, Inc. ('Perspective” or the 'Company”) (NYSE AMERICAN: CATX), a radiopharmaceutical company pioneering advanced treatments for cancers throughout the body, today announced ...

Cytokine networks demonstrate dual functionality. Cytokines are key regulators of immune homeostasis, but paradoxically, cytokines also function as pathogenic drivers in diseases such as systemic ...

Roche’s Itovebi gets European approval to treat people with ER-positive, HER2-negative, advanced breast cancer with a PIK3CA mutation: Basel Thursday, July 24, 2025, 09:00 Hrs [ ...

The first Saturday of May each year marks World Ankylosing Spondylitis (AS) Day, raising awareness of the 54 million patients ...